• Publication & Reference: Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106(19):1503-11.
  • DOI: 10.1136/heartjnl-2020-317393
  • Author(s): Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, et al.
Research Theme | Mental Health & Technology

Publication & Reference

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106(19):1503-11.

DOI

10.1136/heartjnl-2020-317393

Author(s)

Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, et al.
Back to all publications

Contact Us

NIHR Biomedical Research Centre: Nottingham
Research & Innovation
D Floor (via South Block)
Nottingham University Hospitals NHS Trust
Queen’s Medical Centre
Derby Road
Nottingham
NG7 2UH

Telephone: 0115 924 9924

Director: Professor Ian Hall

Hosted by

Nottingham University Hospitals Logo

Nottingham University Hospitals Logo

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute